Procter & Gamble Health Limited · NSE: PGHL · BSE: 500126

Procter & Gamble Health

Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 06 Aug 2026.

Q1 FY27 · Standalone

Revenue
363.71₹ Cr
+7.4% vs year ago
Net profit
96.15₹ Cr
+45.3% vs year ago
EPS, basic
57.92₹
+45.3% vs year ago
Net margin
26.4%
+6.9 pts vs year ago
Revenue₹ crore · standalone · last 12 quarters
Q1 FY24: ₹301.18 CrQ2 FY24: ₹304.93 CrQ3 FY24: ₹309.97 CrQ4 FY24: ₹252.48 CrQ1 FY25: ₹283.88 CrQ2 FY25: ₹313.41 CrQ3 FY25: ₹309.77 CrQ1 FY26: ₹338.74 CrQ2 FY26: ₹324.92 CrQ3 FY26: ₹373.86 CrQ4 FY26: ₹370.45 CrQ1 FY27: ₹363.71 CrQ2 ’24Q4 ’24Q2 ’25Q1 ’26Q3 ’26Q1 ’27
Net profit₹ crore · standalone · last 12 quarters
Q1 FY24: ₹29.82 CrQ2 FY24: ₹65.57 CrQ3 FY24: ₹72.07 CrQ4 FY24: ₹46.56 CrQ1 FY25: ₹16.78 CrQ2 FY25: ₹82.33 CrQ3 FY25: ₹90.90 CrQ1 FY26: ₹66.18 CrQ2 FY26: ₹88.54 CrQ3 FY26: ₹77.59 CrQ4 FY26: ₹94.60 CrQ1 FY27: ₹96.15 CrQ2 ’24Q4 ’24Q2 ’25Q1 ’26Q3 ’26Q1 ’27

Quarter by quarter

Standalone · ₹ crore
QuarterRevenueYoYNet profitYoYEPS (₹)Filed
Q1 FY27Apr–Jun 2026363.71+7.4%96.15+45.3%57.9206 Aug 2026
Q4 FY26Jan–Mar 2026370.45—94.60—56.9927 May 2026
Q3 FY26Oct–Dec 2025373.86+20.7%77.59−14.6%46.7406 Feb 2026
Q2 FY26Jul–Sep 2025324.92+3.7%88.54+7.5%53.3405 Nov 2025
Q1 FY26Apr–Jun 2025338.74+19.3%66.18+294.4%39.8701 Aug 2025
Q3 FY25Oct–Dec 2024309.77−0.1%90.90+26.1%54.7612 Feb 2025
Q2 FY25Jul–Sep 2024313.41+2.8%82.33+25.6%49.6004 Nov 2024
Q1 FY25Apr–Jun 2024283.88−5.7%16.78−43.7%10.1126 Aug 2024
Q4 FY24Jan–Mar 2024252.48−21.3%46.56−21.3%28.0003 May 2024
Q3 FY24Oct–Dec 2023309.97+0.0%72.07−6.2%43.4008 Feb 2024
Q2 FY24Jul–Sep 2023304.93+2.5%65.57+3.0%39.5007 Nov 2023
Q1 FY24Apr–Jun 2023301.18+1.8%29.82−27.6%17.9624 Aug 2023
Q4 FY23Jan–Mar 2023320.92+19.8%59.19+15.7%35.7016 May 2023
Q3 FY23Oct–Dec 2022309.97+11.5%76.80+71.3%46.3006 Feb 2023
Q2 FY23Jul–Sep 2022297.55+9.1%63.66+15.0%38.3013 Nov 2022
Q1 FY23Apr–Jun 2022295.89+3.7%41.19+21.5%24.8030 Aug 2022
Q4 FY22Jan–Mar 2022267.82+22.2%51.16+224.4%30.8006 May 2022
Q3 FY22Oct–Dec 2021277.90+15.7%44.84−33.9%27.0010 Feb 2022
Q2 FY22Jul–Sep 2021272.80+3.3%55.37−6.6%33.4009 Nov 2021
Q1 FY22Apr–Jun 2021285.39—33.89—20.4027 Aug 2021
Q4 FY21Jan–Mar 2021219.15−3.9%15.77−66.1%9.5006 May 2021
Q3 FY21Oct–Dec 2020240.22+1.5%67.88+77.6%40.9011 Feb 2021
Q2 FY21Jul–Sep 2020263.97+17.2%59.26+65.7%35.7012 Nov 2020
Q4 FY20Jan–Mar 2020228.11−1.3%46.46+14.1%27.9905 Jun 2020
Q3 FY20Oct–Dec 2019236.77+15.8%38.21−94.7%23.0207 Feb 2020
Q2 FY20Jul–Sep 2019225.17−0.4%35.76−31.7%21.5408 Nov 2019
Q1 FY20Apr–Jun 2019233.63+6.1%44.08−8.7%26.5609 Aug 2019
Q4 FY19Jan–Mar 2019231.03—40.71—24.5211 May 2019
Q3 FY19Oct–Dec 2018204.39—715.34—430.9427 Feb 2019
Q2 FY19Jul–Sep 2018226.15—52.33—31.5203 Nov 2018
Q1 FY19Apr–Jun 2018220.29—48.31—29.1007 Aug 2018

31 filings on record for this company.